Legal & General Group Plc Sells 22,310 Shares of HealthEquity, Inc. $HQY

Legal & General Group Plc lowered its stake in HealthEquity, Inc. (NASDAQ:HQY) by 14.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 135,356 shares of the company’s stock after selling 22,310 shares during the quarter. Legal & General Group Plc’s holdings in HealthEquity were worth $12,400,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Xponance Inc. raised its holdings in HealthEquity by 0.8% in the 3rd quarter. Xponance Inc. now owns 12,265 shares of the company’s stock worth $1,162,000 after purchasing an additional 102 shares in the last quarter. Truist Financial Corp boosted its stake in shares of HealthEquity by 4.9% during the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after purchasing an additional 119 shares in the last quarter. Fiduciary Trust Co increased its position in shares of HealthEquity by 3.4% during the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after buying an additional 120 shares during the period. Larson Financial Group LLC raised its stake in HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after buying an additional 123 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in HealthEquity by 9.5% in the fourth quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock worth $178,000 after buying an additional 168 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have weighed in on HQY. Raymond James Financial set a $100.00 price objective on HealthEquity in a research report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft increased their target price on HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. Citizens Jmp raised their target price on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research note on Monday. JPMorgan Chase & Co. reduced their price target on HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 18th. Finally, Barclays decreased their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $111.53.

Insider Transactions at HealthEquity

In other news, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director owned 19,733 shares of the company’s stock, valued at $1,775,970. The trade was a 11.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president owned 59,113 shares in the company, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 13,081 shares of company stock valued at $1,193,000. Insiders own 1.60% of the company’s stock.

HealthEquity Price Performance

Shares of HQY opened at $88.34 on Wednesday. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $116.65. The firm’s 50-day simple moving average is $83.63 and its two-hundred day simple moving average is $86.61. The stock has a market cap of $7.39 billion, a PE ratio of 33.09, a price-to-earnings-growth ratio of 1.55 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Analysts anticipate that HealthEquity, Inc. will post 3.84 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.